Advertisement
Grab your lab coat. Let's get started
Welcome!
Welcome!
Create an account below to get 6 C&EN articles per month, receive newsletters and more - all free.
It seems this is your first time logging in online. Please enter the following information to continue.
As an ACS member you automatically get access to this site. All we need is few more details to create your reading experience.
Not you? Sign in with a different account.
Not you? Sign in with a different account.
ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Biological Chemistry
Stand Up To Cancer Forms Dream Teams
by Lisa M. Jarvis
April 27, 2015
| A version of this story appeared in
Volume 93, Issue 17
Stand Up To Cancer (SU2C), an entertainment-industry-backed nonprofit, announced two new rounds of funding to support cancer research. SU2C and the American Cancer Society will together provide $20 million over three years to a “dream team” of cancer researchers studying lung cancer driven by KRAS gene mutations, which are found in up to 25% of lung cancers. Along with several partners, SU2C also formed a dream team for ovarian cancer research. Supported by $6 million over three years, the researchers will explore drugs that target DNA repair pathways.
The power is now in your (nitrile gloved) hands
Sign up for a free account to get more articles. Or choose the ACS option that’s right for you.
Already have an ACS ID? Log in
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter